Curran Uppaluri, MD
Urology · Chapel Hill, NCNPI 1710548789
Payments from drug & device makers
Across 60 payments — averaging $51.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$397
- Urogen Pharma, Inc.$236
- Janssen Scientific Affairs, LLC$235
- AbbVie$162
- Bard Peripheral Vascular, Inc.$150
- plus $792 from 11 others
What the payments were for
- Food & beverage$3,064100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 18 | $1,093 |
| Medtronic | 7 | $397 |
| Urogen Pharma, Inc. | 2 | $236 |
| Janssen Scientific Affairs, LLC | 2 | $235 |
| AbbVie | 7 | $162 |
| Bard Peripheral Vascular, Inc. | 2 | $150 |
| Teleflex LLC | 2 | $138 |
| Procept Biorobotics Corporation | 3 | $136 |
| AstraZeneca | 2 | $118 |
| Johnson & Johnson | 4 | $108 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| Coloplast | 2 | $61 |
| Tolmar, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 1 | $43 |
| Bayer | 1 | $32 |
| Merck | 1 | $22 |
| Astellas Pharma Global Development | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LithoVue$344
- INTERSTIM$229
- GENERAL ERECTILE DYSFUNCTION$129
- Bard BrachySource I-125 Implant Seeds In ReadyLink$127
- JELMYTO$125
- Balversa$122
- UroLift$113
- Erleada$112
How this compares
$3,064 in reported general payments places this provider in the 50th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 20 | $113 |
Paid to pharmacies, not to this prescriber.
Other urology in Chapel Hill
- Angela SmithChapel Hill$428K
- Culley CarsonChapel Hill$275K
- Mathew RaynorChapel Hill$61K
- Matthew NielsenChapel Hill$47K
- Davis ViprakasitChapel Hill$37K
- Gopal NarangChapel Hill$31K
- David FriedlanderChapel Hill$26K
- David JohnsonChapel Hill$25K
- Richard SutherlandChapel Hill$21K
- Daniel GeorgeDurham$17.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.